Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cipla, in collaboration with UNICEF and other partners, has developed the first-of-its kind ‘Mother-Baby Pack' that contains the entire range of anti-retroviral drugs and antibiotics required by an HIV infected mother starting from the 14th week of pregnancy until the 6th week after delivery.
Subscribe to our email newsletter
Cipla said that the ‘Mother-Baby Pack’ has been developed in line with the latest World Health Organisation (WHO) guidelines on Prevention of Mother-to-Child Transmission (PMTCT) Option A .
The Mother-Baby Pack is a color-coded take-home kit with simple graphics to help mothers identify the different sets of drugs each to be taken during pregnancy, during labour and breastfeeding, covering the entire period when the transmission can occur.
The drugs for the Mother-Baby Pack are being manufactured and packaged in Cipla’s manufacturing units in Goa and Patalganga which are approved by WHO-Geneva, USFDA, MHRA-UK and various other regulatory bodies.
Cipla chairman and managing director YK Hamied said they were approached by UNICEF to produce this pack for the PMTCT program.